This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: FB, ONXX, RHT, UA, V

Bed Bath & Beyond numbers lowered at Oppenheimer. Shares of BBBY now seen reaching $80, Oppenheimer said. Estimates also lowered on earnings release. Outperform rating.

Dollar General (DG - Get Report) numbers upped at BofA/Merrill. DG estimates were boosted through 2013, Bank of America/Merrill Lynch said. Company should continue to show solid comp sales momentum. Buy rating and new $60 price target.

Equinix (EQIX) numbers raised at Jefferies. Shares of EQIX now seen reaching $200, Jefferies said. Estimates also raised on market expansion. Buy rating.

Mastercard (MA) estimates, target increased at Morgan Stanley. MA estimates were raised through 2014, Morgan Stanley said. Company has multiple potential growth drivers. Overweight rating and new $535 price target.

Micron (MU) estimates, target cut at Sterne Agee. Shares of MU now seen reaching $10, according to Sterne Agee. Estimates also reduced, given lower pricing and retail demand. Buy rating.

Onyx Pharmaceuticals (ONXX) numbers raised at Goldman. Shares of ONXX now seen reaching $63, according to Goldman Sachs. Estimates also increased, given expected FDA approval for the company's new blood cancer treatment. Buy rating.

Onyx Pharmaceuticals numbers raised at Jefferies. Shares of ONXX now seen reaching $55, Jefferies said. Estimates also raised on Carfilzomib likely being approved. Hold rating.

Procter & Gamble (PG) estimates lowered at Credit Suisse through 2014, Credit Suisse said. Company is seeing slower market growth and losing share. Outperform rating and $70 price target.

Red Hat (RHT) numbers reduced at BMO. RHT estimates were cut through 2014, BMO Capital said. Billings growth has been disappointing. Outperform rating and new $60 price target.

Red Hat target lowered at Citigroup to $66. Lower terminal multiple. Buy rating.

Visa (V) estimates, target boosted at Goldman. Shares of V now seen reaching $147, according to Goldman Sachs. Estimates also upped, given better industry fundamentals. Overweight rating.

Zumiez (ZUMZ) estimates, target raised at Credit Suisse. Shares of ZUMZ now seen reaching $41, according to Credit Suisse. Estimates also increased, as a recent acquisition in Europe should be accretive. Neutral rating.

>To submit a news tip, email:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.
2 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ONXX $0.00 0.00%
ACN $113.30 0.00%
BBBY $46.07 0.00%
DG $82.93 0.00%
FB $117.43 0.00%


Chart of I:DJI
DOW 17,750.91 -140.25 -0.78%
S&P 500 2,063.37 -18.06 -0.87%
NASDAQ 4,763.2240 -54.37 -1.13%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs